Isolation and characterization of simian immunodeficiency virus variants that are resistant to nonnucleoside reverse transcriptase inhibitors

Archives of Virology

Volumn 145, Issue 12, 2000, Pages 2481-2492

  Isaka, Y ^a   Miki, S ^a   Kawauchi, S ^a   Suyama, A ^a   Sugimoto, H ^a   Adachi, A ^b   Hayami, M ^c   Yoshie, O ^d   Fujiwara, T ^a   Sato, A ^a  

^a SHIONOGI AND CO LTD   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; DELAVIRDINE; GENETIC STRAIN; RNA DIRECTED DNA POLYMERASE INHIBITOR; SENSITIVITY; SIMIAN IMMUNODEFICIENCY VIRUS; SITE DIRECTED MUTAGENESIS; VIRUS CHARACTERIZATION; VIRUS MUTATION; VIRUS RESISTANCE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; DELAVIRDINE; DRUG RESISTANCE, MICROBIAL; HELA CELLS; HUMANS; LAMIVUDINE; MOLECULAR SEQUENCE DATA; POINT MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; SEQUENCE ALIGNMENT; SIMIAN IMMUNODEFICIENCY VIRUS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0034530175     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s007050070003     Document Type: Article

References (42)

1. Production of acquired immunodeficiency syndrome-associated retrovirus in human and non-human cells transfected with an infectious molecular clone
2. Amino acid substitution in HIV-1 reverse transcriptase with corresponding residues from HIV-2
3. Complete nucleotide sequence of a simian immunodeficiency virus from African green monkeys: A novel type of intragroup divergence
4. Susceptibilities of human immunodeficiency virus type 1 enzyme and viral expressing multiple resistance-engendering amino acid substitutions to reverse transcriptase inhibitors
5. Mutations at codon 184 in simian immunodeficiency virus reverse transcriptase confer resistance to the (-) enantiomer of 2′,3′-dideoxy-3′-thiacytidine
6. Isolation of a T-cell tropic HTLV-III-like retrovirus from macaques
7. Differential inhibitory effects of TIBO derivatives on different strains of simian immunodeficiency virus
8. HIV inhibitors targeted at the reverse transcriptase
9. The role of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
10. Delavirdine susceptibilities and associated reverse transcriptase mutations in human immunodeficiency virus type 1 isolates from patients in a phase I/II trial of delavirdine monotherapy (ACTG 260)
11. A mutation in reverse transcriptase of bis(heteroaryl)piperazine-resistant human immunodeficiency virus type 1 that confers increased sensitivity to other nonnucleoside inhibitors
12. Characterization of human immunodeficiency virus type 1 strains resistant to the non-nucleoside reverse transcriptase inhibitor RD4-2217
13. S-1153 inhibits replication of known drug-resistant strains of human immunodeficiency virus type 1
14. Sequence of simian immunodeficiency virus from African green monkey, a new member of the HIV/SIV group
15. Isolation of T-lymphotropic retrovirus from naturally infected sooty mangabey monkeys (Cercocebus atys)
16. Simian immunodeficiency viruses and their relationship to the human immunodeficiency virus
17. Genetic organization of a chimpanzee lentivirus related to HIV-1
18. Construction of the chimeric reverse transcriptase of simian immunodeficiency virus sensitive to nonnucleoside reverse transcriptase inhibitor
19. Small amino acid changes in the V3 Loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5
20. Crystal structure of human immunodeficiency virus type 1 reverse transcriptase complexed with double-stranded DNA at 3.0 Å resolution shows bent DNA
21. Establishment of human cytotoxic cell lines specific for human adult T cell leukemia virus-bearing cells
22. Mapping the genetic determinants of human immunodeficiency virus type 2 for cell tropism and replication efficiency
23. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
24. 3′-azido-3′-deoxythymidine resistance suppressed by a mutation conferring human immunodeficiency virus type 1 resistance to nonnucleoside reverse transcriptase inhibitors
25. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys
26. mac
27. Review of HIV-1 everse transcriptase three-dimensional structure: Implications for drug design
28. Mutations within the primer grip region of HIV-1 reverse transcriptase result in loss of RNase H function
29. Isolation and partial characterization of an HIV-related virus occurring naturally in chimpanzees in Gabon
30. Variability among HIV and SIV strains of African origin
31. The catalytic functions of chimeric reverse transcriptases of human immunodeficiency viruses type 1 and type 2
32. Origins and diversity of human immunodeficiency viruses
33. agm
34. Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells
35. Chimeric human immunodeficiency virus type 1/type 2 reverse transcriptase display reversed sensitivity to nonnucleoside analog inhibitors
36. A novel Met-to-Thr mutation in the YMDD motif of reverse transcriptase from feline immunodeficiency virus confers resistance to oxathiolane nucleoside
37. CXCF-4/fusin is not a species-specific barrier in murine cells for HIV-1 entry
38. Rapid in vitro selection of human immunodeficiency virus type 1 resistant to 3′-thiacytidine inhibitors due to a mutation in the YMDD region of reverse transcriptase
39. Isolation and characterization of simian immunodeficiency virus from mandrills in Africa and its relationship to other human and simian immunodeficiency viruse
40. In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
41. L-743,726 (DMP-266): A novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase